INTRODUCTION
============

In recent years, the Internet has become an accessible source of health related information for patients and their carers. Studies have shown that in 2010, an astonishing 80% of internet users which comprised of 59% of all American adults use the Internet to seek medical information \[[@b1-pi-2-4-161],[@b2-pi-2-4-161]\]. The convenience of the Internet as a source of health information and the frequency with which it is used highlights the importance of assessing the quality and validity of Internet health information. As evident in the fields of oncology and uro-oncology the quality of health information published on the Internet is often variable \[[@b3-pi-2-4-161],[@b4-pi-2-4-161]\].

Benign prostatic hyperplasia (BPH) is one of the most common benign conditions in men; its prevalence increases exponentially with age. In a recent estimate approximately 6.5 million of the 27 million Caucasian men 50--79 years of age in the USA were expected to meet the criteria for discussing treatment options for BPH \[[@b5-pi-2-4-161]\]. The acceptance of medical therapy as well as minimally invasive therapies for BPH meant various treatment options are available for patients. However patients are often faced with a vast array of Internet information that are unregulated which may negatively impact upon patients' expectations and informed decision-making \[[@b6-pi-2-4-161],[@b7-pi-2-4-161]\].

Systems such as the Health on the Net (HON) Foundation \[[@b8-pi-2-4-161]\] have been used as a tool to identify quality and reliable health information on the Internet. HON is an accreditation body supported by the World Health Organisation (WHO) that accredits websites according to its key principles of authority, complementarity, confidentiality, attribution, justifiability, transparency of authorship and sponsorship and advertising \[[@b8-pi-2-4-161]\].

We aimed to assess and compare the quality of current Internet information on BPH and its surgical and medical managements across four Western languages: English, French, German and Spanish, utilising the HONcode criteria. We further aimed to perform a quality assessment and comparison based on the types of website sponsors.

MATERIALS AND METHODS
=====================

1.. Internet searching for websites
-----------------------------------

Our methodology has been previously described and utilised in previous publications \[[@b4-pi-2-4-161],[@b9-pi-2-4-161]\]. Using the Google search engine ([www.google.com](www.google.com)), in February 2013, we performed Internet searches for 15 terms associated with BPH and its treatment and assessed just over 9,000 websites. The terms searched were: "*Benign Prostatic Hyperplasia*"; "*Benign Prostatic Hypertrophy*"; "*BPH*"; "*Prostatomegaly*"; "*Benign Prostate Enlargement*"; "*TURP*"; "*Transurethral resection prostate*"; "*Prostatectomy*"; "*Laser prostate surgery*"; "*Greenlight laser prostate*"; "*Holmium laser prostate*"; "*Diode laser prostate*"; "*Medical therapy prostate*"; "*Alpha blocker prostate*" and "*Alpha reductase prostate*". English and equivalent terms in French, German and Spanish (translated from English through use of medical translation services and confirmed by laypersons and doctors having the non-English primary language as their primary language for term accuracy) were utilised.

2.. Internet searching for accredited websites
----------------------------------------------

Based on the observation that patients rarely access more than the first page of search results \[[@b10-pi-2-4-161]\], the first 150 websites yielded by each search were then identified and sequentially screened for quality as defined by the HON Foundation. This was done by applying HON principles through the HONcode toolbar function (downloaded from <http://www.hon.ch/>) \[[@b8-pi-2-4-161]\] for use on any personal computer and automatically activates or "lights-up" toolbar if a website is accredited by the HON foundation. The HON function has been used and assessed in several studies and was thus deemed to be a valid and high calibre tool \[[@b4-pi-2-4-161],[@b11-pi-2-4-161]\].

3.. Analysis of accredited websites likelihood of being viewed
--------------------------------------------------------------

A secondary analysis of the first 150 websites encountered for 'search term' was undertaken as previously described \[[@b4-pi-2-4-161],[@b9-pi-2-4-161],[@b12-pi-2-4-161]\]. Firstly, all returned websites for each term were divided into tertiles (first, middle, and last 50). The proportion of accredited sites in each term and language was then analysed and compared using the chi-square test. The purpose of this analysis was to determine where accredited websites were appearing preferentially i.e., in the pages least likely (last 50) versus the most likely to be viewed (first 50).

4.. Quality control
-------------------

For quality control, an English search ("BPH"), had nonaccredited sites within the first 150 discovered websites manually evaluated using the HON criteria to determine their HON status to ascertain if they fulfilled the criteria despite not being "officially" accredited.

5.. Logistic regression examining variables associated with HON status
----------------------------------------------------------------------

This was conducted using the three major variables of search term, language, and tertiles of the first 150 returned. The referent groups for each variable were the English version and the first 50 websites respectively as these had the highest percentage and/or number of HON accredited websites.

6.. Analysis of website sponsors
--------------------------------

For all groups an analysis was undertaken from English language websites to determine the website sponsors and each was categorized according to prior studies of quality of websites on the Internet \[[@b3-pi-2-4-161],[@b4-pi-2-4-161]\]. In summary, the sites were deemed sponsored by (1) lawyers, (2) nonprofit organizations, (3) government organizations/educational institutions, (4) commercial, (5) surgeons/physicians (and their professional organizations), (6) other health professionals, or (7) other. Sponsorship was determined independently by two examiners firstly by web page retrieved; if sponsorship was not obviously apparent, the website was explored until sponsorship could be determined. The concept of sponsorship is not to be confused with the Google terminology of "sponsored links" either highlighting pages at the start of retrieved search or appearing on the side of the page under a banner. As in prior analysis, such pages were not included throughout the entirety of this study \[[@b4-pi-2-4-161]\]. This however is not to be confused with paid "sponsored links"; either highlighting pages at the start of retrieved search or appearing on the side of the page under a banner such pages were not considered in this study.

7.. Statistical analysis
------------------------

Comparisons of proportions across term and language were performed using the chi-square test (or Fisher exact tests when cell counts were less than 5). All statistical tests were two-sided and significance was defined as *P*\<0.05. Odds ratios and 95% confidence intervals were also calculated from the logistic regression analysis. Analyses were performed using SAS 9.1 (SAS Institute Inc., Cary, NC, USA).

RESULTS
=======

1.. Internet search results for accredited websites
---------------------------------------------------

The total number of websites for each disease term is variable ([Table 1](#t1-pi-2-4-161){ref-type="table"}).

'*BPH*' had the most websites, with approximately 17 million websites followed by '*Medical therapy Prostate*' with 12 million websites. '*Prostatomegaly*' had the least websites listed with only approximately 70,000 websites.

The total percentage of HON accredited sites was notably low across all search terms (median, 8%; [Table 1](#t1-pi-2-4-161){ref-type="table"}). Few terms had above 10% of all websites that were HON accredited. '*Benign Prostatic Hyperplasia*' and '*Medical therapy Prostate*' had only 16% of HON accredited sites ([Table 1](#t1-pi-2-4-161){ref-type="table"}).

In regards to linguistic differences ([Table 2](#t2-pi-2-4-161){ref-type="table"}), English (median, 11%; range 3%--30%) had the greatest percentage of HON accredited sites across all disease search terms, followed by French (11%; 1%--28%), German (7%, 1%--14%), and Spanish (6%; 1%--14%).

When analysed by tertiles to determine where HON accredited sites were more likely to appear, it appeared that HON accreditation was significantly more common in the sites that appear in first tertile ([Table 3](#t3-pi-2-4-161){ref-type="table"}).

Finally the odds ratios (ORs) were calculated demonstrating significant differences with search terms, language or between groups ([Table 4](#t4-pi-2-4-161){ref-type="table"}). Indeed it appeared an Internet search was more likely to be accredited if it was for a medical (OR, 1.15) rather than surgical therapy (OR, 0.71). The first tertile was more likely to return an accredited site over the second (OR, 0.52) whilst again one is almost half as likely to get an accredited site in Spanish compared to English (OR, 0.55).

2.. Analysis of website sponsors
--------------------------------

The sponsor analysis of the 150 websites in four languages revealed that the most commonly encountered sponsors were commercial sites (40%) followed by government organisations or educational institutions (20%) and nonprofit organisations (19%). Other sponsors (15%), other health professionals (4%), surgeons/physicians (4%) sponsored far less sites and lawyer-sponsored sites were not encountered ([Table 5](#t5-pi-2-4-161){ref-type="table"}).

DISCUSSION
==========

It is without a doubt that the Internet has become an accessible source of health information for the general public \[[@b2-pi-2-4-161]\]. Moreover studies have shown that the Internet usage is growing rapidly in adults aged \>50 years with an estimated 76% of these adults search online for health information \[[@b13-pi-2-4-161]\]. Since most BPH patients fall within this age group, knowledge concerning how to acquire high-quality information about the disease and treatment options has become increasingly important. In particular medical therapy has evolved with the uptake of alpha reductase inhibitors now rivalling alpha blockers and other agents being explored \[[@b14-pi-2-4-161]--[@b16-pi-2-4-161]\]. Also, the plethora of minimally invasive and laser alternates to transurethral resection of the prostate are being increasingly expanded. For these patients the quality of information could potentially influence their decision-making as well as the overall satisfaction of their care \[[@b17-pi-2-4-161],[@b18-pi-2-4-161]\].

As demonstrated previously in other oncological studies, the HON foundation found that most websites did not meet their criteria for certification \[[@b4-pi-2-4-161],[@b9-pi-2-4-161],[@b19-pi-2-4-161]\]. Indeed oncology studies sit around 20% whereas it was around 10% for BPH and its medical and surgical management. However, there was no difference in the percentage of HON accredited sites for surgical and medical management of BPH. The result is concerning as it illustrates the substandard, perhaps inaccurate and unreliable information that patients may encounter when searching for information related to their disease.

It was previously recognised that language differences exist regarding website quality \[[@b3-pi-2-4-161],[@b4-pi-2-4-161],[@b20-pi-2-4-161]\]. In our study, English-language searches overall had more website listings and ultimately had more HON accredited sites as compared to French, German, and Spanish. At best, under one third of English websites were HON accredited and at worst, under one fifth of Spanish websites were HON accredited. This study highlights the paucity of good quality comprehensive, multilingual information on BPH available on the Internet.

As well as being a source of health information for patients, Websites often serve as a platform for advertising. Marketing and competing commercial interests play and increasing role in driving health information. This is often at the expense of considered, well-balanced opinion. The analysis of website sponsors in this study suggest that the majority of sponsors comprised mainly of commercial sponsors, which begs the question of whether the information provided is neutral and unbiased or if information serves to promote certain products.

There are a number of limitations of this study. The Internet is dynamic with websites constantly being developed and uploaded. Thus search results may vary depending on time and location. Furthermore other search engines are available apart from 'Google', it would be possible for future analyses to investigate if the various filter systems would make a difference in the quality of websites retrieved. It would also be interesting for future studies to assess the likelihood of commercial vs. noncommercial websites being HON accredited.

In conclusion, a lack of validation of most BPH sites should be appreciated with discrepancies in quality and number of websites across diseases, languages and also between medical and alternate terms. Interestingly, the quality found is significantly lower than that available for oncological Internet searches. Perhaps more awareness is needed to broadcast the relevance of HON certification so that creditable medical health information could be published online. As medical professionals, we should also encourage and participate in the development of informative and ethical health websites so that we could direct patients to them as another reliable source of information.
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###### 

Results of the total websites returned for each term and also the percentage of HON accredited sites (%HON+)

  Terminology/treatment              Term searched              Total websites returned[^a)^](#tfn3-pi-2-4-161){ref-type="table-fn"}   HON accredited (600 per term)[^b)^](#tfn4-pi-2-4-161){ref-type="table-fn"}   *P*-value                     
  ---------------------------------- -------------------------- ---------------------------------------------------------------------- ---------------------------------------------------------------------------- ----------- ----------- ----- ----------
  Terminology                        BPH                        17,861,000                                                             54                                                                           546         600         9     0.0006
  Benign prostatic hyperplasia       3,336,000                  97                                                                     503                                                                          600         16                
  Benign prostatic hypertrophy       949,000                    69                                                                     531                                                                          600         12                
  Prostatomegaly                     72,449                     20                                                                     580                                                                          600         3                 
  Benign prostate enlargement        375,900                    54                                                                     546                                                                          600         9                 
  Total (median\*, sum^\^^)                                     949,000\*                                                              294^\^^                                                                      2,706^\^^   3,000^\^^   9\*   
  Surgical treatments                TURP                       9,387,000                                                              44                                                                           556         600         7     \<0.0001
  Transurethral resection prostate   572,680                    47                                                                     553                                                                          600         8                 
  Prostatectomy                      1,075,700                  70                                                                     530                                                                          600         12                
  Laser prostate surgery             1,796,800                  46                                                                     554                                                                          600         8                 
  Greenlight laser prostate          401,500                    33                                                                     567                                                                          600         6                 
  Holmium laser prostate             395,800                    41                                                                     559                                                                          600         7                 
  Diode laser prostate               580,150                    27                                                                     573                                                                          600         5                 
  Total (median\*, sum^\^^)                                     580,150\*                                                              308^\^^                                                                      3,892^\^^   4,200       7\*   
  Medical treatments                 Medical therapy prostate   12,187,000                                                             94                                                                           506         600         16    \<0.0001
  Alpha blocker prostate             1,496,400                  58                                                                     542                                                                          600         10                
  Alpha reductase prostate           947,500                    50                                                                     550                                                                          600         8                 
  Total (median\*, sum^\^^)                                     580,150\*                                                              611^\^^                                                                      7,189^\^^   600\^       7\*   
  Grand total (median\*, sum^\^^)                               949,000\*                                                              804^\^^                                                                      8,196^\^^   1,800\^     8\*   

The %HON+ according to websites in tertiles (first, second, and third fifty) for each search returned is also indicated. Total websites and percentage of HON accredited sites by treatment options.

HON, Health on the Net foundation; HONcode, toolbar function that allows recognition of accreditation of a website by HON principles; %HON+, percentage of HON accredited sites.

Total websites returned: total of 4 languages---English, French, German & Spanish.

Total of 600 per term: 4 languages×150 websites searched.

###### 

Differences in HON accreditation of websites by term and language

  Terminology/treatment               English   French    German   Spanish   *P*-value                                                            
  ----------------------------------- --------- --------- -------- --------- ----------- ----- -------- --------- ------ -------- --------- ----- ----------
  Terminology                                                                                                                                     \<0.0001
   BPH                                22        128       17       4         146         3     17       133       13     11       139       8     
   Benign prostatic hyperplasia       33        117       28       33        117         28    18       132       14     13       137       9     
   Benign prostatic hypertrophy       22        128       17       18        132         14    13       136       10     15       135       11    
   Prostatomegaly                     4         146       3        5         145         3     9        141       6      2        148       1     
   Benign prostate enlargement        35        115       30       1         149         1     10       140       7      8        142       6     
  Total (median%\*,sum^\^^)           116^\^^   634^\^^   17\*     61^\^^    689^\^^     3\*   67^\^^   682^\^^   10\*   49^\^^   701^\^^   8\*   
  Surgical therapies                                                                                                                              \<0.0001
   TURP                               13        137       9        10        140         7     15       135       11     6        144       4     
   Transurethral resection prostate   6         144       4        22        128         17    7        143       5      12       138       9     
   Prostatectomy                      16        134       12       27        123         22    7        143       5      20       130       15    
   Laser prostate surgery             8         142       6        20        130         15    8        142       6      10       140       7     
   Greenlight laser prostate          6         144       4        16        134         12    8        142       6      3        147       2     
   Holmium laser prostate             12        138       9        14        136         10    13       137       9      2        148       1     
   Diode laser prostate               9         141       6        13        137         9     2        148       1      3        147       2     
  Total                               51        699       6        90        660         12    38       712       6      38       712       4     
  Medical therapies                                                                                                                               0.0006
   Medical therapy prostate           29        121       24       28        122         23    9        141       6      28       122       23    
   Alpha blocker prostate             23        127       18       14        136         10    12       138       9      9        141       6     
   Alpha reductase prostate           17        133       13       14        136         10    10       140       7      9        141       6     
  Total                               129       1,221     18       159       1,191       10    71       1,279     7      87       1,263     6     
  Grand total                         233       1,867     11       235       1,865       11    141      1,958     7      140      1,960     6     

HON, Health on the Net foundation; HONcode, toolbar function that allows recognition of accreditation of a website by HON principles; %HON+, percentage of HON accredited sites; BPH, benign prostatic hyperplasia; TURP, transurethral resection of the prostate.

###### 

Results of the percentage of HON accredited sites by organ group

  Search term                         Tertile 1 (sites 1--50)   Tertile 2 (sites 51--100)   Tertile 3 (sites 101--150)   *P*-value                                   
  ----------------------------------- ------------------------- --------------------------- ---------------------------- ----------- ------- ---- ----- ------- ---- ----------
  Terminology                                                                                                                                                        \<0.0001
   BPH                                36                        164                         22                           10          190     5    8     192     4    
   Benign prostatic hyperplasia       52                        148                         35                           27          173     16   18    182     10   
   Benign prostatic hypertrophy       39                        160                         24                           17          183     9    12    188     6    
   Prostatomegaly                     11                        189                         6                            2           198     1    7     193     4    
   Benign prostate enlargement        32                        168                         19                           17          183     9    5     195     3    
  Total                               170                       829                         21                           73          927     8    50    950     5    
  Surgical therapies                                                                                                                                                 0.0274
   TURP                               17                        183                         9                            14          186     8    13    187     7    
   Transurethral resection prostate   23                        177                         13                           11          189     6    13    187     7    
   Prostatectomy                      24                        176                         14                           23          177     13   23    177     13   
   Laser prostate surgery             23                        177                         13                           11          189     6    12    188     6    
   Greenlight laser prostate          10                        190                         5                            12          188     6    11    189     6    
   Holmium laser prostate             16                        184                         9                            12          188     6    13    187     7    
   Diode laser prostate               11                        189                         6                            8           192     4    8     192     4    
  Total                               84                        916                         9                            66          934     7    67    933     7    
  Medical therapies                                                                                                                                                  \<0.0001
   Medical therapy prostate           45                        155                         29                           27          173     16   22    178     12   
   Alpha blocker prostate             30                        170                         18                           12          188     6    16    184     9    
   Alpha reductase prostate           25                        175                         14                           15          185     8    10    190     5    
  Total                               195                       1,605                       12                           128         1,672   8    123   1,677   7    

The %HON+ according to for websites in tertiles (first, second, and third fifty) for each search returned is also indicated.

HON, Health on the Net foundation; HONcode, toolbar function that allows recognition of accreditation of a website by HON principles; %HON+, percentage of HON accredited sites; BPH, benign prostatic hyperplasia; TURP, transurethral resection of the prostate.

###### 

Results of the logistic regression analysis comparing across BPH terminology, likelihood of an accredited website based on first, second and third 50 websites returned and by language

  Effect on HONcode status                                 Odds ratio (95% confidence limits)
  -------------------------------------------------------- ------------------------------------
  Category                                                 
   BPH condition                                           1.00 (referent)
   Medical therapy                                         1.149 (0.950--1.391)
   Surgical therapy                                        0.714 (0.603--0.844)
  Websites[^a)^](#tfn10-pi-2-4-161){ref-type="table-fn"}   
   1st Tertile (0--50)                                     1.00 (referent)
   2nd Tertile (51--100)                                   0.524 (0.440--0.623)
   3rd Tertile (101--150)                                  0.445 (0.371--0.534)
  Language                                                 
   English                                                 1.00 (referent)
   French                                                  0.929 (0.769--1.121)
   German                                                  0.607 (0.493--0.746)
   Spanish                                                 0.558 (0.452--0.690)

Referents were chosen based on the term BPH and its alternate terms being the standard; the first tertile returned because of this having the greatest percentage of HON accredited websites and English as the most common language.

BPH, benign prostatic hyperplasia; HON, Health on the Net foundation.

Of the first 150 websites examined the first third or 50 (5 pages) were reference group compared to second third and last third.

###### 

Results of the analysis of website sponsors by organ malignancy (or alternate term) across the English language sites only

  Disease terms searched              Lawyer   Nonprofit    Government/education   Commercial   Other health professionals   Physician/surgeon   Others       *P*-value
  ----------------------------------- -------- ------------ ---------------------- ------------ ---------------------------- ------------------- ------------ -----------
  Terminology/treatment                                                                                                                                       \<0.0001
   BPH                                0 (0)    87 (15)      105 (18)               228 (38)     28 (5)                       23 (4)              129 (22)     
   Benign prostatic hyperplasia       0 (0)    97 (16)      99 (17)                252 (42)     29 (5)                       43 (7)              80 (13)      
   Benign prostatic hypertrophy       0 (0)    103 (17)     86 (14)                212 (35)     17 (3)                       41(7)               141 (24)     
   Prostatomegaly                     0 (0)    96 (16)      67 (11)                164 (27)     5 (1)                        113 (19)            155 (26)     
   Benign prostate enlargement        0 (0)    125 (21)     132 (22)               237 (40)     22 (4)                       29 (5)              55 (9)       
  Surgical technique                                                                                                                                          \<0.0001
   TURP                               0 (0)    86 (14)      93 (16)                153 (26)     17 (3)                       4 (1)               247 (41)     
   Transurethral resection prostate   0 (0)    95 (16)      160 (27)               265 (44)     16 (3)                       2 (0)               62 (10)      
   Prostatectomy                      0 (0)    116 (19)     166 (28)               224 (37)     26 (4)                       3 (0)               66 (11)      
   Laser prostate surgery             0 (0)    119 (20)     178 (30)               191 (32)     27 (5)                       7 (1)               78 (13)      
   Greenlight laser prostate          0 (0)    113 (19)     160 (27)               221 (37)     39 (7)                       5 (1)               62 (10)      
   Holmium laser prostate             0 (0)    114 (19)     133 (22)               273 (46)     25 (4)                       2 (0)               53 (9)       
   Diode laser prostate               0 (0)    76 (13)      89 (15)                337 (56)     13 (2)                       7 (1)               78 (13)      
  Medical therapy                                                                                                                                             
   m\\Medical therapy prostate        0 (0)    141 (24)     133 (22)               263 (44)     22 (4)                       18 (3)              23 (4)       
   Alpha blocker prostate             0 (0)    172 (29)     78 (13)                288 (48)     15 (2)                       19 (3)              28 (5)       \<0.0001
   Alpha reductase prostate           3 (1)    145 (24)     66 (11)                289 (48)     19 (3)                       32 (5)              46 (8)       
  Total (mean %)                      3 (0)    1,685 (19)   1,745 (20)             3,597 (40)   320 (4)                      348 (4)             1,303 (15)   

Values are presented as number (%).

BPH, benign prostatic hyperplasia; TURP, transurethral resection of the prostate.
